Patent · US Active

Method and nucleic acids for the analysis of colon cell proliferative disorders

US9988683B2 · kind B2 · utility

0Cited by

14References

35Claims

0Family size

Assignee

EPIGENOMICS AG · DE

Inventors

Peter Adorjan · Berlin, DE
Matthias Burger · Bad Birnbach, DE
Sabine Maier · Brussels, BE
Ralf Lesche · Berlin, DE
Susan Cottrell · Seattle, US
Suzanne Mooney · Seattle, US

Key dates

Filing date	Jun 4, 2010
Grant date	Jun 5, 2018
Priority date	—
Expiry date	May 21, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/143333
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are methods and nucleic acids for detecting, differentiating or distinguishing between colon cell proliferative disorders by analysis of one or more of the genes Versican, TPEF, H-Cadherin, Calcitonin, and EYA4. Further provided are novel nucleic acid sequences useful for the cell proliferative disorder specific analysis of said genes as well as methods, assays and kits thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.